US Patent Issued to ELASMOGEN on July 29 for "Specific binding molecules" (British Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,484, issued on July 29, was assigned to ELASMOGEN LTD (Aberdeen, Great Britain).

"Specific binding molecules" was invented by Obinna Ubah (Aberdeen, Great Britain), Caroline Barelle (Aberdeen, Great Britain) and Andrew Porter (Aberdeen, Great Britain).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to the formation of multi-domain specific binding molecules comprising VNARs. Specific binding domains that bind to Tumour Necrosis Factor alpha (TNFAlpha) are also provided."

The patent was filed on Feb. 13, 2024, under Application No. 18/440,437.

*For further information, including images, charts and tables, please visit: h...